<div class="container">

<table style="width: 100%;"><tr>
<td>TRTR.RTRT</td>
<td style="text-align: right;">R Documentation</td>
</tr></table>
<h2>
Reference Datasets for TRTR|RTRT Designs
</h2>

<h3>Description</h3>

<p>Datasets from the public domain, edited, or obtained by simulations to be evaluated by <code>method.A()</code> and/or <code>method.B()</code>.
</p>


<h3>Format</h3>


<ul>
<li>
<p> Reference dataset 01<br>
77 subjects.<br>
Unbalanced (39 subjects in sequence TRTR and 38 in RTRT) and incomplete (seven missings in sequence TRTR and three in sequence RTRT). Missings / period: 0/1, 1/2, 7/3, 2/4. Two outliers (subjects 45 and 52) in sequence RTRT.<br>
A data frame with 298 observations on the following 6 variables:
</p>

<dl>
<dt>rds01</dt>
<dd>

<table>
<tr>
<td style="text-align: left;">
          <code>subject</code> </td>
<td style="text-align: left;"> a factor with 77 levels: 1, 2, ..., 78</td>
</tr>
<tr>
<td style="text-align: left;">
          <code>period</code> </td>
<td style="text-align: left;"> a factor with 4 levels: 1, 2, 3, 4</td>
</tr>
<tr>
<td style="text-align: left;">
          <code>sequence</code> </td>
<td style="text-align: left;"> a factor with 2 levels: TRTR, RTRT</td>
</tr>
<tr>
<td style="text-align: left;">
          <code>treatment</code> </td>
<td style="text-align: left;"> a factor with 2 levels: T, R</td>
</tr>
<tr>
<td style="text-align: left;">
          <code>PK</code> </td>
<td style="text-align: left;"> a numeric vector of pharmacokinetic responses acceptable for reference-scaling (generally C<sub>max</sub>)</td>
</tr>
<tr>
<td style="text-align: left;">
          <code>logPK</code> </td>
<td style="text-align: left;"> a numeric vector of the natural logarithms of <code>PK</code>
        </td>
</tr>
</table>
</dd>
</dl>
<p>In the source evaluated by <abbr><span class="acronym">SAS</span></abbr> v9.1 for <abbr><span class="acronym">ABEL</span></abbr>. Reported results:

</p>
<dl>
<dt>SAS Proc GLM</dt>
<dd>

<table>
<tr>
<td style="text-align: left;">
        <code>CVwR</code> </td>
<td style="text-align: left;"> 47.0%</td>
</tr>
<tr>
<td style="text-align: left;">
        <code>PE</code> </td>
<td style="text-align: left;"> 115.66% (Method A)</td>
</tr>
<tr>
<td style="text-align: left;"></td>
<td style="text-align: left;"> 115.73% (Method B)</td>
</tr>
<tr>
<td style="text-align: left;">
        <code>90% CI</code> </td>
<td style="text-align: left;"> 107.11% – 124.89% (Method A)</td>
</tr>
<tr>
<td style="text-align: left;"></td>
<td style="text-align: left;"> 107.17% – 124.97% (Method B)
      </td>
</tr>
</table>
</dd>
</dl>
</li>
<li>
<p> Reference dataset 06<br>
Based on <code>rds01</code>. 77 subjects. Responses of T and R switched.<br>
Unbalanced (39 subjects in sequence TRTR and 38 in RTRT) and incomplete (seven missings in sequence TRTR and three in sequence RTRT). Missings / period: 0/1, 1/2, 7/3, 2/4. No outliers.<br>
A data frame with 298 observations on the following 6 variables:
</p>

<dl>
<dt>rds06</dt>
<dd>

<table>
<tr>
<td style="text-align: left;">
          <code>subject</code> </td>
<td style="text-align: left;"> a factor with 77 levels: 1, 2, ..., 78</td>
</tr>
<tr>
<td style="text-align: left;">
          <code>period</code> </td>
<td style="text-align: left;"> a factor with 4 levels: 1, 2, 3, 4</td>
</tr>
<tr>
<td style="text-align: left;">
          <code>sequence</code> </td>
<td style="text-align: left;"> a factor with 2 levels: TRTR, RTRT</td>
</tr>
<tr>
<td style="text-align: left;">
          <code>treatment</code> </td>
<td style="text-align: left;"> a factor with 2 levels: T, R</td>
</tr>
<tr>
<td style="text-align: left;">
          <code>PK</code> </td>
<td style="text-align: left;"> a numeric vector of pharmacokinetic responses acceptable for reference-scaling (generally C<sub>max</sub>)
        </td>
</tr>
</table>
</dd>
</dl>
</li>
<li>
<p> Reference dataset 08<br>
Simulated with slight heteroscedasticity (CV<sub>wT</sub> = 70%, CV<sub>wR</sub> = 80%), CV<sub>bT</sub> = CV<sub>bR</sub> = 150%, GMR = 0.85. 222 subjects.<br>
Balanced (222 subjects in both sequences) and complete. No outliers.<br>
The extreme sample size results from high variability, an assumed true GMR 0.85, and target power 90%.<br>
A data frame with 888 observations on the following 5 variables:
</p>

<dl>
<dt>rds08</dt>
<dd>

<table>
<tr>
<td style="text-align: left;">
          <code>subject</code> </td>
<td style="text-align: left;"> a factor with 222 levels: 1, 2, ..., 222</td>
</tr>
<tr>
<td style="text-align: left;">
          <code>period</code> </td>
<td style="text-align: left;"> a factor with 4 levels: 1, 2, 3, 4</td>
</tr>
<tr>
<td style="text-align: left;">
          <code>sequence</code> </td>
<td style="text-align: left;"> a factor with 2 levels: TRTR, RTRT</td>
</tr>
<tr>
<td style="text-align: left;">
          <code>treatment</code> </td>
<td style="text-align: left;"> a factor with 2 levels: T, R</td>
</tr>
<tr>
<td style="text-align: left;">
          <code>PK</code> </td>
<td style="text-align: left;"> a numeric vector of pharmacokinetic responses acceptable for reference-scaling (generally C<sub>max</sub>)
        </td>
</tr>
</table>
</dd>
</dl>
</li>
<li>
<p> Reference dataset 09<br>
Based on <code>rds08</code>. Wide numeric range (data of last 37 subjects multiplied by 1,000,000). 222 subjects.<br>
Balanced (222 subjects in both sequences) and complete. No outliers.<br>
A data frame with 888 observations on the following 5 variables:
</p>

<dl>
<dt>rds09</dt>
<dd>

<table>
<tr>
<td style="text-align: left;">
          <code>subject</code> </td>
<td style="text-align: left;"> a factor with 222 levels: 1, 2, ..., 222</td>
</tr>
<tr>
<td style="text-align: left;">
          <code>period</code> </td>
<td style="text-align: left;"> a factor with 4 levels: 1, 2, 3, 4</td>
</tr>
<tr>
<td style="text-align: left;">
          <code>sequence</code> </td>
<td style="text-align: left;"> a factor with 2 levels: TRTR, RTRT</td>
</tr>
<tr>
<td style="text-align: left;">
          <code>treatment</code> </td>
<td style="text-align: left;"> a factor with 2 levels: T, R</td>
</tr>
<tr>
<td style="text-align: left;">
          <code>PK</code> </td>
<td style="text-align: left;"> a numeric vector of pharmacokinetic responses acceptable for reference-scaling (generally C<sub>max</sub>)
        </td>
</tr>
</table>
</dd>
</dl>
</li>
<li>
<p> Reference dataset 12<br>
Simulated with extreme intra- and intersubject variability, GMR = 1.6487. 77 subjects.<br>
Unbalanced (39 subjects in sequence TRTR and 38 in RTRT) and incomplete (seven missings in sequence TRTR and three in sequence RTRT). Missings / period: 0/1, 1/2, 7/3, 2/4. No outliers.<br>
A data frame with 298 observations on the following 6 variables:
</p>

<dl>
<dt>rds12</dt>
<dd>

<table>
<tr>
<td style="text-align: left;">
          <code>subject</code> </td>
<td style="text-align: left;"> a factor with 77 levels: 1, 2, ..., 78</td>
</tr>
<tr>
<td style="text-align: left;">
          <code>period</code> </td>
<td style="text-align: left;"> a factor with 4 levels: 1, 2, 3, 4</td>
</tr>
<tr>
<td style="text-align: left;">
          <code>sequence</code> </td>
<td style="text-align: left;"> a factor with 2 levels: TRTR, RTRT</td>
</tr>
<tr>
<td style="text-align: left;">
          <code>treatment</code> </td>
<td style="text-align: left;"> a factor with 2 levels: T, R</td>
</tr>
<tr>
<td style="text-align: left;">
          <code>PK</code> </td>
<td style="text-align: left;"> a numeric vector of pharmacokinetic responses acceptable for reference-scaling (generally C<sub>max</sub>)
        </td>
</tr>
</table>
</dd>
</dl>
</li>
<li>
<p> Reference dataset 13<br>
Based on <code>rds08</code>. Highly incomplete (approx. 50% of period 4 data deleted). 222 subjects.<br>
Balanced (111 subjects in both sequences) and incomplete (56 missings in both sequences). Missings / period: 0/0, 0/0, 0/0, 112/4. No outliers.<br>
A data frame with 776 observations on the following 5 variables:
</p>

<dl>
<dt>rds13</dt>
<dd>

<table>
<tr>
<td style="text-align: left;">
          <code>subject</code> </td>
<td style="text-align: left;"> a factor with 222 levels: 1, 2, ..., 222</td>
</tr>
<tr>
<td style="text-align: left;">
          <code>period</code> </td>
<td style="text-align: left;"> a factor with 4 levels: 1, 2, 3, 4</td>
</tr>
<tr>
<td style="text-align: left;">
          <code>sequence</code> </td>
<td style="text-align: left;"> a factor with 2 levels: TRTR, RTRT</td>
</tr>
<tr>
<td style="text-align: left;">
          <code>treatment</code> </td>
<td style="text-align: left;"> a factor with 2 levels: T, R</td>
</tr>
<tr>
<td style="text-align: left;">
          <code>PK</code> </td>
<td style="text-align: left;"> a numeric vector of pharmacokinetic responses acceptable for reference-scaling (generally C<sub>max</sub>)
        </td>
</tr>
</table>
</dd>
</dl>
</li>
<li>
<p> Reference dataset 14<br>
Simulated with high variability, GMR = 1. Dropouts as a hazard function growing with period. 77 subjects.<br>
Unbalanced (39 subjects in sequence TRTR and 38 in RTRT) and incomplete (18 missings in sequence TRTR and 17 in sequence RTRT). Missings / period: 0/1, 4/2, 12/3, 19/4. No outliers.<br>
A data frame with 273 observations on the following 6 variables:
</p>

<dl>
<dt>rds14</dt>
<dd>

<table>
<tr>
<td style="text-align: left;">
          <code>subject</code> </td>
<td style="text-align: left;"> a factor with 77 levels: 1, 2, ..., 78</td>
</tr>
<tr>
<td style="text-align: left;">
          <code>period</code> </td>
<td style="text-align: left;"> a factor with 4 levels: 1, 2, 3, 4</td>
</tr>
<tr>
<td style="text-align: left;">
          <code>sequence</code> </td>
<td style="text-align: left;"> a factor with 2 levels: TRTR, RTRT</td>
</tr>
<tr>
<td style="text-align: left;">
          <code>treatment</code> </td>
<td style="text-align: left;"> a factor with 2 levels: T, R</td>
</tr>
<tr>
<td style="text-align: left;">
          <code>PK</code> </td>
<td style="text-align: left;"> a numeric vector of pharmacokinetic responses acceptable for reference-scaling (generally C<sub>max</sub>)
        </td>
</tr>
</table>
</dd>
</dl>
</li>
<li>
<p> Reference dataset 15<br>
Based on <code>ref08</code>. Highly incomplete (approx. 50% of period 4 data coded as missing <code>'NA'</code>). 222 subjects.<br>
Balanced (111 subjects in both sequences) and incomplete (56 missings in both sequences). Missings / period: 0/1, 0/2, 0/3, 112/4. No outliers.<br>
A data frame with 888 observations (112 <code>NA</code>) on the following 5 variables
</p>

<dl>
<dt>rds15</dt>
<dd>

<table>
<tr>
<td style="text-align: left;">
          <code>subject</code> </td>
<td style="text-align: left;"> a factor with 222 levels: 1, 2, ..., 222</td>
</tr>
<tr>
<td style="text-align: left;">
          <code>period</code> </td>
<td style="text-align: left;"> a factor with 4 levels: 1, 2, 3, 4</td>
</tr>
<tr>
<td style="text-align: left;">
          <code>sequence</code> </td>
<td style="text-align: left;"> a factor with 2 levels: TRTR, RTRT</td>
</tr>
<tr>
<td style="text-align: left;">
          <code>treatment</code> </td>
<td style="text-align: left;"> a factor with 2 levels: T, R</td>
</tr>
<tr>
<td style="text-align: left;">
          <code>PK</code> </td>
<td style="text-align: left;"> a numeric vector of pharmacokinetic responses acceptable for reference-scaling (generally C<sub>max</sub>)
        </td>
</tr>
</table>
</dd>
</dl>
</li>
<li>
<p> Reference dataset 18<br>
Data set based on <code>rds14</code>. Removed T data of subjects 63–78. 77 subjects.<br>
Unbalanced (39 subjects in sequence TRTR and 38 in RTRT) and incomplete (32 missings in sequence TRTR and 31 in sequence RTRT). Missings / period: 8/1, 12/2, 18/3, 25/4. No outliers.<br>
A data frame with 245 observations on the following 6 variables:
</p>

<dl>
<dt>rds18</dt>
<dd>

<table>
<tr>
<td style="text-align: left;">
          <code>subject</code> </td>
<td style="text-align: left;"> a factor with 77 levels: 1, 2, ..., 78</td>
</tr>
<tr>
<td style="text-align: left;">
          <code>period</code> </td>
<td style="text-align: left;"> a factor with 4 levels: 1, 2, 3, 4</td>
</tr>
<tr>
<td style="text-align: left;">
          <code>sequence</code> </td>
<td style="text-align: left;"> a factor with 2 levels: TRTR, RTRT</td>
</tr>
<tr>
<td style="text-align: left;">
          <code>treatment</code> </td>
<td style="text-align: left;"> a factor with 2 levels: T, R</td>
</tr>
<tr>
<td style="text-align: left;">
          <code>PK</code> </td>
<td style="text-align: left;"> a numeric vector of pharmacokinetic responses acceptable for reference-scaling (generally C<sub>max</sub>)
        </td>
</tr>
</table>
</dd>
</dl>
</li>
<li>
<p> Reference dataset 19<br>
Data set based on <code>rds18</code>. Removed data of subjects 63–78. 61 subjects.<br>
Unbalanced (31 subjects in sequence TRTR and 30 in RTRT) and incomplete (14 missings in both sequences). Missings / period: 0/1, 4/2, 9/3, 15/4. Two outliers (subjects 18 and 51 in sequence RTRT).<br>
A data frame with 216 observations on the following 6 variables:
</p>

<dl>
<dt>rds19</dt>
<dd>

<table>
<tr>
<td style="text-align: left;">
          <code>subject</code> </td>
<td style="text-align: left;"> a factor with 61 levels: 1, 2, ..., 62</td>
</tr>
<tr>
<td style="text-align: left;">
          <code>period</code> </td>
<td style="text-align: left;"> a factor with 4 levels: 1, 2, 3, 4</td>
</tr>
<tr>
<td style="text-align: left;">
          <code>sequence</code> </td>
<td style="text-align: left;"> a factor with 2 levels: TRTR, RTRT</td>
</tr>
<tr>
<td style="text-align: left;">
          <code>treatment</code> </td>
<td style="text-align: left;"> a factor with 2 levels: T, R</td>
</tr>
<tr>
<td style="text-align: left;">
          <code>PK</code> </td>
<td style="text-align: left;"> a numeric vector of pharmacokinetic responses acceptable for reference-scaling (generally C<sub>max</sub>)
        </td>
</tr>
</table>
</dd>
</dl>
</li>
<li>
<p> Reference dataset 20<br>
Data set based on <code>rds19</code>. Extreme outlier of R (subject 1) introduced: original value ×100). 61 subjects.<br>
Unbalanced (31 subjects in sequence TRTR and 30 in RTRT) and incomplete (14 missings in both sequences). Missings / period: 0/1, 4/2, 9/3, 15/4. Two outliers (subjects 1 and 51 in sequence RTRT).<br>
A data frame with 216 observations on the following 6 variables:
</p>

<dl>
<dt>rds20</dt>
<dd>

<table>
<tr>
<td style="text-align: left;">
          <code>subject</code> </td>
<td style="text-align: left;"> a factor with 61 levels: 1, 2, ..., 62</td>
</tr>
<tr>
<td style="text-align: left;">
          <code>period</code> </td>
<td style="text-align: left;"> a factor with 4 levels: 1, 2, 3, 4</td>
</tr>
<tr>
<td style="text-align: left;">
          <code>sequence</code> </td>
<td style="text-align: left;"> a factor with 2 levels: TRTR, RTRT</td>
</tr>
<tr>
<td style="text-align: left;">
          <code>treatment</code> </td>
<td style="text-align: left;"> a factor with 2 levels: T, R</td>
</tr>
<tr>
<td style="text-align: left;">
          <code>PK</code> </td>
<td style="text-align: left;"> a numeric vector of pharmacokinetic responses acceptable for reference-scaling (generally C<sub>max</sub>)
        </td>
</tr>
</table>
</dd>
</dl>
</li>
<li>
<p> Reference dataset 21<br>
Based on <code>ds01</code>. 77 subjects. One extreme result of subjects 45 &amp; 52 set to NA.<br>
Unbalanced (39 subjects in sequence TRTR and 38 in RTRT) and incomplete (seven missings in sequence TRTR and five in sequence RTRT). Missings / period: 1/1, 1/2, 8/3, 2/4. No outliers.<br>
A data frame with 298 observations (2 NA) on the following 6 variables:
</p>

<dl>
<dt>rds21</dt>
<dd>

<table>
<tr>
<td style="text-align: left;">
          <code>subject</code> </td>
<td style="text-align: left;"> a factor with 61 levels: 1, 2, ..., 62</td>
</tr>
<tr>
<td style="text-align: left;">
          <code>period</code> </td>
<td style="text-align: left;"> a factor with 4 levels: 1, 2, 3, 4</td>
</tr>
<tr>
<td style="text-align: left;">
          <code>sequence</code> </td>
<td style="text-align: left;"> a factor with 2 levels: TRTR, RTRT</td>
</tr>
<tr>
<td style="text-align: left;">
          <code>treatment</code> </td>
<td style="text-align: left;"> a factor with 2 levels: T, R</td>
</tr>
<tr>
<td style="text-align: left;">
          <code>PK</code> </td>
<td style="text-align: left;"> a numeric vector of pharmacokinetic responses acceptable for reference-scaling (generally C<sub>max</sub>)
        </td>
</tr>
</table>
</dd>
</dl>
</li>
<li>
<p> Reference dataset 25<br>
Simulated with heteroscedasticity (CV<sub>wT</sub> = 50%, CV<sub>wR</sub> = 80%), CV<sub>bT</sub> = CV<sub>bR</sub> = 130%, GMR = 0.85. 70 subjects.<br>
Balanced (70 subjects in both sequences) and complete. No outliers.<br>
A data frame with 280 observations on the following 5 variables:
</p>

<dl>
<dt>rds25</dt>
<dd>

<table>
<tr>
<td style="text-align: left;">
          <code>subject</code> </td>
<td style="text-align: left;"> a factor with 70 levels: 1, 2, ..., 70</td>
</tr>
<tr>
<td style="text-align: left;">
          <code>period</code> </td>
<td style="text-align: left;"> a factor with 4 levels: 1, 2, 3, 4</td>
</tr>
<tr>
<td style="text-align: left;">
          <code>sequence</code> </td>
<td style="text-align: left;"> a factor with 2 levels: TRTR, RTRT</td>
</tr>
<tr>
<td style="text-align: left;">
          <code>treatment</code> </td>
<td style="text-align: left;"> a factor with 2 levels: T, R</td>
</tr>
<tr>
<td style="text-align: left;">
          <code>PK</code> </td>
<td style="text-align: left;"> a numeric vector of pharmacokinetic responses acceptable for reference-scaling (generally C<sub>max</sub>)
        </td>
</tr>
</table>
</dd>
</dl>
</li>
<li>
<p> Reference dataset 26<br>
54 subjects.<br>
Balanced (27 subjects in both sequences) and incomplete (two missings in both sequences). Missings / period: 0/1, 0/2, 2/3, 2/4. One outlier (subject 49) in sequence RTRT.<br>
A data frame with 216 observations on the following 5 variables:
</p>

<dl>
<dt>rds26</dt>
<dd>

<table>
<tr>
<td style="text-align: left;">
          <code>subject</code> </td>
<td style="text-align: left;"> a factor with 54 levels: 1, 2, ..., 57</td>
</tr>
<tr>
<td style="text-align: left;">
          <code>period</code> </td>
<td style="text-align: left;"> a factor with 4 levels: 1, 2, 3, 4</td>
</tr>
<tr>
<td style="text-align: left;">
          <code>sequence</code> </td>
<td style="text-align: left;"> a factor with 2 levels: TRTR, RTRT</td>
</tr>
<tr>
<td style="text-align: left;">
          <code>treatment</code> </td>
<td style="text-align: left;"> a factor with 2 levels: T, R</td>
</tr>
<tr>
<td style="text-align: left;">
          <code>PK</code> </td>
<td style="text-align: left;"> a numeric vector of pharmacokinetic responses acceptable for reference-scaling (here C<sub>max</sub>)
        </td>
</tr>
</table>
</dd>
</dl>
<p>In the source evaluated by <abbr><span class="acronym">SAS</span></abbr> for <abbr><span class="acronym">ABEL</span></abbr>. Reported results (Method A):
</p>
<dl>
<dt>SAS Proc GLM</dt>
<dd>

<table>
<tr>
<td style="text-align: left;">
          <code>CVwR</code> </td>
<td style="text-align: left;"> 60.25%</td>
</tr>
<tr>
<td style="text-align: left;">
          <code>PE</code> </td>
<td style="text-align: left;"> 151.3%</td>
</tr>
<tr>
<td style="text-align: left;">
          <code>90% CI</code> </td>
<td style="text-align: left;"> 133.5% – 171.4%
        </td>
</tr>
</table>
</dd>
</dl>
</li>
<li>
<p> Reference dataset 29<br>
Simulated with heteroscedasticity (CV<sub>wT</sub> = 14%, CV<sub>wR</sub> = 28%, CV<sub>bT</sub> = 28%, CV<sub>bR</sub> = 56%), GMR = 0.90. 12 subjects.<br>
Imbalanced (five subjects in sequence TRTR and seven in sequence RTRT) and incomplete (three missings in sequence TRTR and four in sequence RTRT). Missings / period: 0/1, 1/2, 2/3, 4/4. One outlier (subject 11) in sequence RTRT.<br>
A data frame with 41 observations on the following 5 variables:
</p>

<dl>
<dt>rds29</dt>
<dd>

<table>
<tr>
<td style="text-align: left;">
          <code>subject</code> </td>
<td style="text-align: left;"> a factor with 12 levels: 1, 2, ..., 20</td>
</tr>
<tr>
<td style="text-align: left;">
          <code>period</code> </td>
<td style="text-align: left;"> a factor with 4 levels: 1, 2, 3, 4</td>
</tr>
<tr>
<td style="text-align: left;">
          <code>sequence</code> </td>
<td style="text-align: left;"> a factor with 2 levels: TRTR, RTRT</td>
</tr>
<tr>
<td style="text-align: left;">
          <code>treatment</code> </td>
<td style="text-align: left;"> a factor with 2 levels: T, R</td>
</tr>
<tr>
<td style="text-align: left;">
          <code>PK</code> </td>
<td style="text-align: left;"> a numeric vector of pharmacokinetic responses acceptable for reference-scaling (generally C<sub>max</sub>)
        </td>
</tr>
</table>
</dd>
</dl>
</li>
</ul>
<h3>Details</h3>


<table>
<tr>
<td style="text-align: center;">
    Dataset </td>
<td style="text-align: right;"> N </td>
<td style="text-align: center;"> CV<sub>wR</sub> (%) </td>
<td style="text-align: left;"> Evaluation</td>
</tr>
<tr>
<td style="text-align: center;">
    <code>rds01</code> </td>
<td style="text-align: right;"> 77 </td>
<td style="text-align: center;"> &gt;30 </td>
<td style="text-align: left;"> <code>method.A()</code>, <code>method.B()</code>
</td>
</tr>
<tr>
<td style="text-align: center;">
    <code>rds06</code> </td>
<td style="text-align: right;"> 77 </td>
<td style="text-align: center;"> &gt;30 </td>
<td style="text-align: left;"> <code>method.A()</code>, <code>method.B()</code>
</td>
</tr>
<tr>
<td style="text-align: center;">
    <code>rds08</code> </td>
<td style="text-align: right;"> 222 </td>
<td style="text-align: center;"> &gt;30 </td>
<td style="text-align: left;"> <code>method.A()</code>, <code>method.B()</code>
</td>
</tr>
<tr>
<td style="text-align: center;">
    <code>rds09</code> </td>
<td style="text-align: right;"> 222 </td>
<td style="text-align: center;"> &gt;30 </td>
<td style="text-align: left;"> <code>method.A()</code>, <code>method.B()</code>
</td>
</tr>
<tr>
<td style="text-align: center;">
    <code>rds12</code> </td>
<td style="text-align: right;"> 77 </td>
<td style="text-align: center;"> &gt;30 </td>
<td style="text-align: left;"> <code>method.A()</code>, <code>method.B()</code>
</td>
</tr>
<tr>
<td style="text-align: center;">
    <code>rds13</code> </td>
<td style="text-align: right;"> 222 </td>
<td style="text-align: center;"> &gt;30 </td>
<td style="text-align: left;"> <code>method.A()</code>, <code>method.B()</code>
</td>
</tr>
<tr>
<td style="text-align: center;">
    <code>rds14</code> </td>
<td style="text-align: right;"> 77 </td>
<td style="text-align: center;"> &gt;30 </td>
<td style="text-align: left;"> <code>method.A()</code>, <code>method.B()</code>
</td>
</tr>
<tr>
<td style="text-align: center;">
    <code>rds15</code> </td>
<td style="text-align: right;"> 222 </td>
<td style="text-align: center;"> &gt;30 </td>
<td style="text-align: left;"> <code>method.A()</code>, <code>method.B()</code>
</td>
</tr>
<tr>
<td style="text-align: center;">
    <code>rds18</code> </td>
<td style="text-align: right;"> 77 </td>
<td style="text-align: center;"> &gt;30 </td>
<td style="text-align: left;"> <code>method.A()</code>, <code>method.B()</code>
</td>
</tr>
<tr>
<td style="text-align: center;">
    <code>rds19</code> </td>
<td style="text-align: right;"> 61 </td>
<td style="text-align: center;"> &gt;30 </td>
<td style="text-align: left;"> <code>method.A()</code>, <code>method.B()</code>
</td>
</tr>
<tr>
<td style="text-align: center;">
    <code>rds20</code> </td>
<td style="text-align: right;"> 61 </td>
<td style="text-align: center;"> &gt;30 </td>
<td style="text-align: left;"> <code>method.A()</code>, <code>method.B()</code>
</td>
</tr>
<tr>
<td style="text-align: center;">
    <code>rds21</code> </td>
<td style="text-align: right;"> 77 </td>
<td style="text-align: center;"> &gt;30 </td>
<td style="text-align: left;"> <code>method.A()</code>, <code>method.B()</code>
</td>
</tr>
<tr>
<td style="text-align: center;">
    <code>rds25</code> </td>
<td style="text-align: right;"> 70 </td>
<td style="text-align: center;"> &gt;30 </td>
<td style="text-align: left;"> <code>method.A()</code>, <code>method.B()</code>
</td>
</tr>
<tr>
<td style="text-align: center;">
    <code>rds26</code> </td>
<td style="text-align: right;"> 54 </td>
<td style="text-align: center;"> &gt;30 </td>
<td style="text-align: left;"> <code>method.A()</code>, <code>method.B()</code>
</td>
</tr>
<tr>
<td style="text-align: center;">
    <code>rds29</code> </td>
<td style="text-align: right;"> 12 </td>
<td style="text-align: center;"> &lt;30 </td>
<td style="text-align: left;"> <code>method.A()</code>, <code>method.B()</code>, <code>ABE()</code>
  </td>
</tr>
</table>
<h3>Note</h3>

<p>In software sequences and treatments are ranked in lexical order. Hence, executing <code>str()</code> or <code>summary()</code> will show <code>sequence</code> as <code>"RTRT", "TRTR"</code> and <code>treatment</code> as <code>"R", "T"</code>. In <abbr><span class="acronym">BE</span></abbr> – by convention – sequences are ordered with <code>T</code> first. The package follows this convention.
</p>


<h3>Author(s)</h3>

<p>Helmut Schütz (R-code for simulations by Detlew Labes), Michael Tomashevskiy (simulations in Phoenix NLME)
</p>


<h3>Source</h3>


<table>
<tr>
<td style="text-align: center;">
    Dataset </td>
<td style="text-align: left;"> Origin </td>
<td style="text-align: left;"> Description</td>
</tr>
<tr>
<td style="text-align: center;">
    <code>rds01</code> </td>
<td style="text-align: left;"> EMA </td>
<td style="text-align: left;"> Annex II.</td>
</tr>
<tr>
<td style="text-align: center;">
    <code>rds06</code> </td>
<td style="text-align: left;"> <code>rds01</code> edited </td>
<td style="text-align: left;"> T and R switched.</td>
</tr>
<tr>
<td style="text-align: center;">
    <code>rds08</code> </td>
<td style="text-align: left;"> R </td>
<td style="text-align: left;"> Large simulated data set with slight heteroscedasticity.</td>
</tr>
<tr>
<td style="text-align: center;">
    <code>rds09</code> </td>
<td style="text-align: left;"> <code>rds08</code> </td>
<td style="text-align: left;"> Wide numeric range (data of last 37 subjects multiplied by 1,000,000).</td>
</tr>
<tr>
<td style="text-align: center;">
    <code>rds12</code> </td>
<td style="text-align: left;"> Phoenix NLME </td>
<td style="text-align: left;"> Simulated with extreme intra- and intersubject variability.</td>
</tr>
<tr>
<td style="text-align: center;">
    <code>rds13</code> </td>
<td style="text-align: left;"> <code>rds08</code> edited </td>
<td style="text-align: left;"> Highly incomplete (approx. 50% of period 4 data deleted).</td>
</tr>
<tr>
<td style="text-align: center;">
    <code>rds14</code> </td>
<td style="text-align: left;"> Phoenix NLME </td>
<td style="text-align: left;"> Simulated with high intra-/intersubject variability and</td>
</tr>
<tr>
<td style="text-align: center;">
     </td>
<td style="text-align: left;"> </td>
<td style="text-align: left;">  number of dropouts increasing with period.</td>
</tr>
<tr>
<td style="text-align: center;">
    <code>rds15</code> </td>
<td style="text-align: left;"> <code>rds08</code> edited </td>
<td style="text-align: left;"> Highly incomplete (approx. 50% of period 4 data coded as missing <code>'NA'</code>).</td>
</tr>
<tr>
<td style="text-align: center;">
    <code>rds18</code> </td>
<td style="text-align: left;"> <code>rds14</code> edited </td>
<td style="text-align: left;"> Removed T data of subjects 63–78.</td>
</tr>
<tr>
<td style="text-align: center;">
    <code>rds19</code> </td>
<td style="text-align: left;"> <code>rds18</code> edited </td>
<td style="text-align: left;"> Removed data of subjects 63–78.</td>
</tr>
<tr>
<td style="text-align: center;">
    <code>rds20</code> </td>
<td style="text-align: left;"> <code>rds19</code> edited </td>
<td style="text-align: left;"> Outlier of R (subject 1) introduced: original value ×100.</td>
</tr>
<tr>
<td style="text-align: center;">
    <code>rds21</code> </td>
<td style="text-align: left;"> <code>rds01</code> edited </td>
<td style="text-align: left;"> One extreme result of subjects 45 &amp; 52 set to NA.</td>
</tr>
<tr>
<td style="text-align: center;">
    <code>rds25</code> </td>
<td style="text-align: left;"> R </td>
<td style="text-align: left;"> Simulated with heteroscedasticity.</td>
</tr>
<tr>
<td style="text-align: center;">
    <code>rds26</code> </td>
<td style="text-align: left;"> Patterson &amp; Jones </td>
<td style="text-align: left;"> C<sub>max</sub> data given in Tables 4.40 and 4.31.</td>
</tr>
<tr>
<td style="text-align: center;">
    <code>rds29</code> </td>
<td style="text-align: left;"> R </td>
<td style="text-align: left;"> Simulated with heteroscedasticity; imbalanced and incomplete.
  </td>
</tr>
</table>
<h3>References</h3>

<p>European Medicines Agency. London, 21 September 2016. <a href="https://www.ema.europa.eu/en/documents/other/31-annex-i-statistical-analysis-methods-compatible-ema-bioequivalence-guideline_en.pdf"><em>Annex I</em></a>, <a href="https://www.ema.europa.eu/en/documents/other/31-annex-ii-statistical-analysis-bioequivalence-study-example-data-set_en.pdf"><em>Annex II</em></a>.
</p>
<p>Patterson SD, Jones B. <em>Bioequivalence and Statistics in Clinical Pharmacology.</em> Boca Raton: CRC Press; 2<sup>nd</sup> edition 2016. p105–6.
</p>


<h3>Examples</h3>

<pre><code class="language-R">str(rds01)
summary(rds01[2:6])
</code></pre>


</div>